NewsBenzingaEli Lilly Announces FDA Approval Of Inluriyo In Combination With Verzenio For Treatment Of Adults With ER+, HER2–, ESR1-Mutated Locally Advanced Or Metastatic Breast Cancer Eli Lilly Announces FDA Approval Of Inluriyo In Combination With Verzenio For Treatment Of Adults With ER+, HER2–, ESR1-Mutated Locally Advanced Or Metastatic Breast Cancer Benzinga 2026.09.18 17:58 (GMT+0) Open on Benzinga Other news Piper Sandler Maintains Neutral on SoundHound AI, Lowers Price Target to $6 Piper Sandler Maintains Overweight on Motorola Solutions, Raises Price Target to $531 HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target Why Is Carnival Stock Surging on Tuesday? Here's How Much $100 Invested In First Citizens BancShares 5 Years Ago Would Be Worth Today EXCLUSIVE: Small AI Model Matches GPT-4.1 at Forecasting as Olas Founding Member Says Frontier Models Face ‘Increasing Economic Pressure’
EXCLUSIVE: Small AI Model Matches GPT-4.1 at Forecasting as Olas Founding Member Says Frontier Models Face ‘Increasing Economic Pressure’
